JOHNSON PHARMACARE LIMITED

Services · Commercial Services & Supplies

BSE: 532154
₹0.42
▲ 0.00 (0.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
16/100
Weak
Valuation
—/100
Expensive
Momentum
43/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹23 Cr
PE (TTM)
Data unavailable.
Price to Book
53.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-48.2
Free Cash Flow
₹-58 Cr
as of March 31, 2026
Industry median ₹-0 Cr (372 companies)
EPS Growth (YoY)
-10000.00%
as of March 31, 2026
Industry median 0.00% (300 companies)
Net Profit Growth (TTM)
-9411.06%
as of June 30, 2026
Industry median 0.00% (325 companies)
Operating Revenue Growth (TTM)
0.00%
as of June 30, 2026
Industry median 0.00% (317 companies)
Profit Growth (YoY)
-1981.13%
as of June 30, 2026
Industry median 2.13% (293 companies)
Revenue Growth (YoY)
64.73%
as of June 30, 2022
Industry median 7.61% (227 companies)
Current Ratio
11.89
as of March 31, 2026
Industry median 2.48 (345 companies)
Debt to Equity
49.18
as of March 31, 2026
Industry median 0.06 (315 companies)
Interest Coverage
-41.98
as of June 30, 2026
Industry median 2.71 (293 companies)
Net Margin
15.71%
as of June 30, 2022
Industry median 3.80% (247 companies)
Operating Margin (EBIT)
13.13%
as of March 31, 2009
Industry median 6.24% (257 companies)
Operating Margin (TTM)
-846.72%
as of June 30, 2026
Industry median 4.63% (310 companies)
Return on Assets
-252.97%
as of March 31, 2026
Industry median 0.99% (329 companies)
Return on Capital Employed
-254.03%
as of March 31, 2026
Industry median 2.68% (300 companies)
Return on Equity
-12805.84%
as of March 31, 2026
Industry median 2.11% (328 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (49.18)
  • No Return on equity is 15% or more (-12805.8%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

1 of 1 met
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 0.4100 · High 0.4300
1W return
-4.5%
Low 0.4100 · High 0.4500
1M return
-8.7%
Low 0.4100 · High 0.4700
52W return
-63.2%
Low 0.4100 · High 0.4800
Lifetime High ₹107.3500 (Feb. 12, 2014)
Lifetime Low ₹0.3900 (March 28, 2023)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
0.4
10D
0.4
20D
0.5
50D
0.6
100D
0.7
200D
0.8

Delivery and volume

Day avg. delivery
60.8%
Week avg. delivery
59.1%
Month avg. delivery
62.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

0.42
Pivot
First resistance0.43
Second resistance0.44
Third resistance0.45
First support0.41
Second support0.40
Third support0.39
Day RSI28.0
Day MFI13.2
Day MACD-0.04
Day MACD signal-0.04

Beta

1M0.70
3M0.79
1Y0.79
3Y0.32

Price change analysis

↓ -8.7%
Over 1 Month
LowHigh
0.410.47
↓ -63.2%
Over 3 Months
LowHigh
0.410.48
↓ -63.2%
Over 6 Months
LowHigh
0.410.48
↓ -63.2%
Over 1 Year
LowHigh
0.410.48
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹— Cr
Net profit (June 30, 2026)
₹-1 Cr
Basic EPS (June 30, 2026)
₹-0.0200

Ranks #170 of 315 in Commercial Services & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Data unavailable.

Full shareholding pattern →

DateClientDealActionQuantityPriceExchange
5 Jul 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Buy 300,000 1.1900 BSE
5 Jul 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 5,495,207 1.2000 BSE
5 Jul 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 6,777,253 1.1900 BSE
4 Jul 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 38,463 1.1500 BSE
4 Jul 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 2,777,253 1.1500 BSE
27 Jun 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 4,585,505 0.9500 BSE
27 Jun 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Buy 5,037,152 0.9500 BSE
19 Jan 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 3,000,000 0.9800 BSE
18 Jan 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 544,816 1.0200 BSE
18 Jan 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Buy 3,000,000 1.0000 BSE

All bulk and block deals →

Corporate Actions

Full history (3 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Robinson Impex India Ltd. to Sun and Shine Worldwide Ltd
—NAME_CHANGEName changed from ROBINSON WORLDWIDE TRADE LTD. to Sun and Shine Worldwide Ltd
—NAME_CHANGEName changed from Sun and Shine Worldwide Ltd to JOHNSON PHARMACARE LIMITED

All corporate actions →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong revenue growth YoY (64.7%)

Weaknesses

  • Low Return on Equity (-12805.8%)
  • High financial leverage (Debt/Equity 49.18)
  • Declining profit YoY (-1981.1%)

Opportunities

  • RSI in oversold territory (28.0) -- a technical rebound zone

Threats

  • Down 63.2% over the past year
  • Weak interest coverage (-42.0x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about JOHNSON PHARMACARE LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.